Profile
Claus Steensen Sølje is currently Director at Novo Nordisk Pharma Operations A since 2017.
Mr. Sølje is also Director at Sonion A. Since 2023, Mr. Sølje has been Chief Financial Officer & Executive Vice President at ALK-Abello A. Mr. Sølje graduated from the University of Copenhagen in 1999.
Claus Steensen Sølje active positions
| Companies | Position | Start |
|---|---|---|
| ALK-ABELLÓ A/S | Director of Finance/CFO | 2023-05-31 |
Novo Nordisk Pharma Operations AS
Novo Nordisk Pharma Operations AS Pharmaceuticals: OtherHealth Technology Engages in the pharmaceutical and medicine manufacturing industry | Director/Board Member | 2017-04-24 |
Sonion A/S
Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Director/Board Member | - |
Education of Claus Steensen Sølje
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sonion A/S
Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Health Technology |
Novo Nordisk Pharma Operations AS
Novo Nordisk Pharma Operations AS Pharmaceuticals: OtherHealth Technology Engages in the pharmaceutical and medicine manufacturing industry | Health Technology |
- Stock Market
- Insiders
- Claus Steensen Sølje
















